| Literature DB >> 24366037 |
Michael J Waring1, David M Andrews, Paul F Faulder, Vikki Flemington, Jennifer C McKelvie, Sarita Maman, Marian Preston, Piotr Raubo, Graeme R Robb, Karen Roberts, Rachel Rowlinson, James M Smith, Martin E Swarbrick, Iris Treinies, Jon J G Winter, Robert J Wood.
Abstract
Two series of inhibitors of type III phosphatidylinositol-4-kinase were identified by high throughput screening and optimised to derive probe compounds that independently and selectively inhibit the α- and the β-isoforms with no significant activity towards related kinases in the pathway. In a cellular environment, inhibition of the α- but not the β-subtype led to a reduction in phosphatidylinositol-4-phosphate and phosphatidylinositol-4,5-bisphosphate concentration, causing inhibition of inositol-1-phosphate formation and inhibition of proliferation in a panel of cancer cell lines.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24366037 DOI: 10.1039/c3cc48391f
Source DB: PubMed Journal: Chem Commun (Camb) ISSN: 1359-7345 Impact factor: 6.222